Evidence mapPaperPMID 22483976Full record

Trial reportMetabolism: clinical and experimental2012

Vascular effects of intravenous intralipid and dextrose infusions in obese subjects.

Aidar R Gosmanov, Dawn D Smiley, Limin Peng, Joselita Siquiera, Gonzalo Robalino, Christopher Newton, Guillermo E Umpierrez

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Metabolism: clinical and experimental, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Reply to the letter to the editor.European heart journal. Case reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aidar R GosmanovDepartment of Medicine, Division of Endocrinology University of Tennessee Health Science Center, Memphis, TN, USA.
Dawn D Smiley
Limin Peng
Joselita Siquiera
Gonzalo Robalino
Christopher Newton
Guillermo E Umpierrez
Emory University · US

Funding

X LINKED NYSTAGMUS SYNDROME WITH FEATURES OF ALBINISMM01RR000039 · EMORY UNIVERSITY · 1985 to 2005
$18.2M
NCATS NIH HHS UL1 TR000454NCRR NIH HHS M01 RR000039NCRR NIH HHS MO1-RR00039NIDDK NIH HHS K08 DK083036
6 · The paper itself

Abstract

Hyperglycemia and elevated free fatty acids (FFA) are implicated in the development of endothelial dysfunction. Infusion of soy-bean oil-based lipid emulsion (Intralipid®) increases FFA levels and results in elevation of blood pressure (BP) and endothelial dysfunction in obese healthy subjects. The effects of combined hyperglycemia and high FFA on BP, endothelial function and carbohydrate metabolism are not known. Twelve obese healthy subjects received four random, 8-h IV infusions of saline, Intralipid 40 mL/h, Dextrose 10% 40 mL/h, or combined Intralipid and dextrose. Plasma levels of FFA increased by 1.03±0.34 mmol/L (p=0.009) after Intralipid, but FFAs remained unchanged during saline, dextrose, and combined Intralipid and dextrose infusion. Plasma glucose and insulin concentrations significantly increased after dextrose and combined Intralipid and dextrose (all, p<0.05) and were not different from baseline during saline and lipid infusion. Intralipid increased systolic BP by 12±9 mmHg (p<0.001) and diastolic BP by 5±6 mmHg (p=0.022),and decreased flow-mediated dilatation (FMD) from baseline by 3.2%±1.4% (p<0.001). Saline and dextrose infusion had neutral effects on BP and FMD. The co-administration of lipid and dextrose decreased FMD by 2.4%±2.1% (p=0.002) from baseline, but did not significantly increase systolic or diastolic BP. Short-term Intralipid infusion significantly increased FFA and BP; in contrast, FFA and BP were unchanged during combined infusion of Intralipid and dextrose. Combined Intralipid and dextrose infusion resulted in endothelial dysfunction similar to Intralipid alone.

Indexed as

AdultBlood GlucoseBlood PressureC-PeptideEmulsionsEndothelium, VascularFatty Acids, NonesterifiedFemaleGlucoseHumansInfusions, IntravenousInsulinMaleMiddle AgedObesityPhospholipidsBlood GlucoseC-PeptideEmulsionsFatty Acids, NonesterifiedGlucoseInsulinPhospholipidsSoybean Oilsoybean oil, phospholipid emulsionTriglycerides

Identifiers

PMID22483976
PMCPMC3738183
OpenAlexW2022333407

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.